The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Table of Contents
Global Antibody-drug Conjugates Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Antibody-drug Conjugates Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Adcetris Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Kadcyla Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Antibody-drug Conjugates Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Antibody-drug Conjugates Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Antibody-drug Conjugates Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Antibody-drug Conjugates Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Antibody-drug Conjugates Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Antibody-drug Conjugates Market Assessment by Type
8.1 Asia Pacific Antibody-drug Conjugates Market Assessment by Application (Consumption and Market Share)
8.2 North America Antibody-drug Conjugates Market Assessment by Application (Consumption and Market Share)
8.3 Europe Antibody-drug Conjugates Market Assessment by Application (Consumption and Market Share)
8.4 South America Antibody-drug Conjugates Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Antibody-drug Conjugates Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 ImmunoGen
9.1.1 ImmunoGen Profiles
9.1.2 ImmunoGen Product Portfolio
9.1.3 ImmunoGen Antibody-drug Conjugates Business Performance
9.1.4 ImmunoGen Antibody-drug Conjugates Business Development and Market Status
9.2 Seattle Genetics
9.2.1 Seattle Genetics Profiles
9.2.2 Seattle Genetics Product Portfolio
9.2.3 Seattle Genetics Antibody-drug Conjugates Business Performance
9.2.4 Seattle Genetics Antibody-drug Conjugates Business Development and Market Status
9.3 Roche
9.3.1 Roche Profiles
9.3.2 Roche Product Portfolio
9.3.3 Roche Antibody-drug Conjugates Business Performance
9.3.4 Roche Antibody-drug Conjugates Business Development and Market Status
9.4 Takeda
9.4.1 Takeda Profiles
9.4.2 Takeda Product Portfolio
9.4.3 Takeda Antibody-drug Conjugates Business Performance
9.4.4 Takeda Antibody-drug Conjugates Business Development and Market Status
10 World Antibody-drug Conjugates Market Assessment by Players
10.1 Global Antibody-drug Conjugates Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Antibody-drug Conjugates Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Antibody-drug Conjugates Price (USD/Unit) of Players 2014-2020
10.4 Global Antibody-drug Conjugates Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Antibody-drug Conjugates Sales Assessment of Players 2014-2020
11.1.2 North America Antibody-drug Conjugates Revenue Assessment of Players 2014-2020
11.1.3 North America Antibody-drug Conjugates Price Assessment of Players 2014-2020
11.1.4 North America Antibody-drug Conjugates Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Antibody-drug Conjugates Sales Assessment of Players 2014-2020
11.2.2 Europe Antibody-drug Conjugates Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Antibody-drug Conjugates Price Assessment of Players 2014-2020
11.2.4 Europe Antibody-drug Conjugates Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Antibody-drug Conjugates Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Antibody-drug Conjugates Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Antibody-drug Conjugates Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Antibody-drug Conjugates Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Antibody-drug Conjugates Sales Assessment of Players 2014-2020
11.4.2 South America Antibody-drug Conjugates Revenue Assessment of Players 2014-2020
11.4.3 South America Antibody-drug Conjugates Price Assessment of Players 2014-2020
11.4.4 South America Antibody-drug Conjugates Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Antibody-drug Conjugates Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Antibody-drug Conjugates Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Antibody-drug Conjugates Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Antibody-drug Conjugates Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Antibody-drug Conjugates Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Antibody-drug Conjugates Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Antibody-drug Conjugates Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Antibody-drug Conjugates Sales by Countries/Regions 2014-2020
12.2.2 North America Antibody-drug Conjugates Revenue by Countries/Regions 2014-2020
12.2.3 North America Antibody-drug Conjugates Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Antibody-drug Conjugates Sales by Countries/Regions 2014-2020
12.3.2 Europe Antibody-drug Conjugates Revenue by Countries/Regions 2014-2020
12.3.3 Europe Antibody-drug Conjugates Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Antibody-drug Conjugates Sales by Countries/Regions 2014-2020
12.4.2 South America Antibody-drug Conjugates Revenue by Countries/Regions 2014-2020
12.4.3 South America Antibody-drug Conjugates Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Antibody-drug Conjugates Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Antibody-drug Conjugates Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Antibody-drug Conjugates Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Antibody-drug Conjugates Sales & Revenue Forecast 2021-2026
14.1 World Antibody-drug Conjugates Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Antibody-drug ConjugatesSales and Market Share by Regions
14.1.2 World Antibody-drug ConjugatesRevenue and Market Share by Regions
15 Asia Antibody-drug Conjugates Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Adcetris
15.1.2 Kadcyla
15.2 Consumption Forecast by Application, 2021-2026
16 North America Antibody-drug Conjugates Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Adcetris
16.1.2 Kadcyla
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Antibody-drug Conjugates Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Adcetris
17.1.2 Kadcyla
17.2 Consumption Forecast by Application, 2021-2026
18 South America Antibody-drug Conjugates Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Adcetris
18.1.2 Kadcyla
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Antibody-drug Conjugates Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Adcetris
19.1.2 Kadcyla
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Antibody-drug Conjugates Price (USD/Unit) Trend 2021-2026
20.2 Global Antibody-drug Conjugates Gross Profit Trend 2021-2026
21 Conclusion
Price : US$ 3,500 | Date : Apr 2024 |
Category : Manufacturing and Construction | Pages : 139 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Services | Pages : 120 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Manufacturing and Construction | Pages : 125 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Services | Pages : 150 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 139 |
We will be happy to help you find what you need. Please call us or write to us: